机译:P3.02B-060对临床实践中EGFR突变NSCLC的三个/第2代EGFR-TKI的疗效对比分析
Respiratory Center Matsusaka Municipal Hospital;
Matusaka Municipal Hospital;
Respiratory Center Matsusaka Municipal Hospital;
Matusaka Municipal Hospital;
Respiratory Center Matsusaka Municipal Hospital;
Thoracic Surgery Matsusaka Municipal Hospital;
Respiratory Center Matsusaka Municipal Hospital;
Thoracic Surgery Matsusaka Municipal Hospital;
Mie Prefectural General Medical Center;
Mie Prefectural General Medical Center;
Respiratory Division Mie University Graduate School of Medicine;
Department of Immunology Mie University Graduate School of Medicine;
Respiratory Division Mie University Graduate School of Medicine;
机译:P3.02B-060对临床实践中EGFR突变NSCLC的三个/第2代EGFR-TKI的疗效对比分析
机译:1ST / 2ND代EGFR-TKI对非小细胞肺癌(NSCLC)和胸腔积液患者的疗效
机译:P3.02B-049 EGFR-突变的NSCLC:临床实践评估和差距分析
机译:下一代测序对非小细胞肺癌抗蛋白酶激酶抑制剂进行下一代测序检测的低负荷EGFR突变的预测疗效
机译:EGFR-TKIs在非小细胞肺癌治疗中的有效性:一项荟萃分析。
机译:第一代EGFR-TKI加上化疗与EGFR-TKI单独作为高级NSCLC的一线治疗具有EGFR激活突变:随机对照试验的系统评价和荟萃分析
机译:P3.02B-060对临床实践中EGFR突变NSCLC的三个/第2代EGFR-TKI的疗效对比分析